Assess the Benefits From the AAISafeR/SafeR Algorithm of Symphony 2550 or REPLYTM DR in a Wide Range of Pacemaker Patients.

Explore clinical trials studying Assess the Benefits From the AAISafeR/SafeR Algorithm of Symphony 2550 or REPLYTM DR in a Wide Range of Pacemaker Patients.. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Assess the Benefits From the AAISafeR/SafeR Algorithm of Symphony 2550 or REPLYTM DR in a Wide Range of Pacemaker Patients. trial results

Completed

Evaluation of the SafeR Mode in Patients With a Dual Chamber Pacemaker Indication

NCT00562107

Conditions: Assess the Benefits From the AAISafeR/SafeR Algorithm of Symphony 2550 or REPLYTM DR in a Wide Range of Pacemaker Patients.
Locations: 736 Cambridge Street Brighton, Massachusetts, United States

CHU - Hopital Sud Amiens, France

Centre hospitalier de Béthune Béthune, France

CHU - Hopital Michallon Grenoble, France

View all 37 locations

View Trial Details